BUKWANG PHARMACEUTICAL IND CO.,LTD
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
003000 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 동작구 대방동1길 47, 서울특별시
- Website:
- https://www.bukwang.co.kr/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Bukwang Pharmaceutical Co., Ltd. is an R&D-focused pharmaceutical company engaged in the development, manufacturing, and commercialization of therapeutic drugs. The company employs an 'open innovation' strategy, utilizing strategic investments, joint ventures, research collaborations, and acquisitions to expand its drug pipeline and enhance its global competitiveness. Its development pipeline targets a range of conditions, with a focus on central nervous system (CNS) disorders such as schizophrenia (Lurasidone) and Parkinson's disease (JM-010), as well as oncology (SOL-804 for prostate cancer), liver diseases, and metabolic disorders. Through continuous research and strategic partnerships, Bukwang aims to become a global pharmaceutical innovator.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BUKWANG PHARMACEUTICAL IND CO.,LTD and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-29 00:00 |
Related Party Transaction
대규모기업집단현황공시[분기별공시(개별회사용)]
|
Korean | 10.5 KB | |
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.6 MB | |
| 2025-08-14 00:00 |
Regulatory News Service
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
|
Korean | 11.3 KB | |
| 2025-07-24 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 86.0 KB | |
| 2025-07-24 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.4 KB | |
| 2025-07-24 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.4 KB | |
| 2025-07-22 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 20.8 KB | |
| 2025-07-21 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 21.2 KB | |
| 2025-07-16 00:00 |
Share Issue/Capital Change
증권발행실적보고서
|
Korean | 196.6 KB | |
| 2025-07-16 00:00 |
Share Issue/Capital Change
유상증자또는주식관련사채등의발행결과(자율공시)
|
Korean | 8.5 KB | |
| 2025-07-16 00:00 |
Report Publication Announcement
기업설명회(IR)개최(안내공시)
|
Korean | 6.2 KB | |
| 2025-07-15 00:00 |
Share Issue/Capital Change
유상증자또는주식관련사채등의청약결과(자율공시)
|
Korean | 11.3 KB | |
| 2025-07-15 00:00 |
Related Party Transaction
[기재정정]특수관계인의유상증자참여
|
Korean | 12.3 KB | |
| 2025-07-10 00:00 |
Share Issue/Capital Change
유상증자또는주식관련사채등의청약결과(자율공시)
|
Korean | 12.1 KB | |
| 2025-07-10 00:00 |
Related Party Transaction
[기재정정]특수관계인의유상증자참여
|
Korean | 12.9 KB |
Automate Your Workflow. Get a real-time feed of all BUKWANG PHARMACEUTICAL IND CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BUKWANG PHARMACEUTICAL IND CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
